FIELD: medicine; dermatology; cosmetology.
SUBSTANCE: invention can be used for the treatment of steroid rosacea. Six procedures of 20 minutes each are carried out with an interval of once every two weeks, during each of which injections of 1% hyaluronic acid are performed without any local anesthesia into nine acupuncture points. After that, in 15 minutes, 20% lactic acid and 20% arginine are applied to the skin and left for 2 minutes.
EFFECT: method allows to relieve xerosis, perform sebum regulation, restore work in the vascular component, restore the protective properties of the skin, by combining injection therapy with 1% hyaluronic acid at acupuncture points with peeling.
1 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PHYMATOUS SUBTYPE OF ROSACEA BY POINTS | 2023 |
|
RU2814360C1 |
METHOD OF TREATING GRANULOMATOUS SUBTYPE OF ROSACEA BY POINTS | 2023 |
|
RU2810402C1 |
METHOD OF TREATING ROSACEA WITH SOLID PERSISTENT OEDEMA BY POINTS | 2023 |
|
RU2814362C1 |
METHOD OF TREATING ROSACEA CONGLOBATE BY POINTS | 2023 |
|
RU2811255C1 |
METHOD OF TREATING OPHTHALMIC ROSACEA BY POINTS | 2023 |
|
RU2810361C1 |
METHOD OF TREATING PAPULOPUSTULAR SUBTYPE OF ROSACEA BY POINTS | 2023 |
|
RU2814358C1 |
METHOD OF TREATING ERYTHEMATOTELANGIECTATIC SUBTYPE OF ROSACEA BY POINTS | 2023 |
|
RU2811254C1 |
METHOD OF COMPLEX EXTRINSIC FOR PATIENTS WITH ERITHEMATOUS PAPULAR ROSACEA | 2017 |
|
RU2645932C1 |
METHOD OF TREATING SKIN ROSACEA DISEASE | 2008 |
|
RU2351355C1 |
METHOD FOR COMBINATION THERAPY FOR ROSACEA OF ERITHEMATOUS-TELEANGECTATIC SUBTYPE | 2021 |
|
RU2766973C1 |
Authors
Dates
2023-12-27—Published
2023-04-28—Filed